Edimer
Cambridge, United States · $40.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Business Model
- B2B
- Website
- edimerpharma.com
- Total Funding
- $40.0M
- Last Round
- $18.0M Series BJul 2013
- Rounds
- 2
About
Biotechnology company developing targeted therapies for rare genetic diseases, including X-linked Hypohidrotic Ectodermal Dysplasia (XLHED).
Summary
Edimer is a Biotech company based in Cambridge, United States. It has raised $40.0M in total across 2 rounds, most recently a $18.0M Series B round in Jul 2013. Investors include Third Rock Ventures, New Enterprise Associates and VI Partners.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2013
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...